Potential Risks and Considerations Even setting aside regulatory status, any consideration of growth hormone stimulating compounds requires awareness of potential risks that appear in the clinical and safety literature: Water retention and edema Joint pain (arthralgia), which is a known side effect of GH elevation Potential impact on insulin sensitivity GH affects glucose metabolism Theoretical concerns about stimulating GH in individuals with undiagnosed malignancies (GH is a growth factor) Unknown long-term effects from extended use in healthy adults Quality and purity concerns when obtained outside regulated pharmaceutical channels These considerations underscore why any decision regarding peptide therapy must involve a physician who can review individual medical history, contraindications, and current evidence not a wellness clinic, online pharmacy, or influencer recommendation
This means that even if you take a high dose, your cells may only receive a fraction of it
Chronic straining from constipation puts repeated downward pressure on the pelvic floor, increasing the risk of stress incontinence, urge incontinence, and in more significant cases, pelvic organ prolapse
BPC-157 is part of a doctor-supervised peptide therapy program and requires a medical consultation before initiation.
These include: Personal or family history of medullary thyroid cancer or multiple endocrine neoplasias Personal or family history of parathyroid cancer or pancreatic cancer Being pregnant, trying to get pregnant, or breastfeeding History of anorexia, bulimia, or body dysmorphic disorder Type 1 diabetes Diabetic retinopathy Renal insufficiency Vitamin B12 allergy History of pancreatitis or pancreatic disease History of gallbladder disease ( NOTE : If your gallbladder has been removed, you can be considered for semaglutide use) Common Side-Effects As with any medication, there are some common potential side effects from semaglutide use